The Nonclinical Development team at Appello Pharmaceuticals designs and executes preclinical studies to evaluate the safety and efficacy of lead compounds. They collaborate closely on strategic planning and toxicological assessments to support clinical trial readiness and regulatory submissions for treatments targeting Parkinson's disease.